Multiply Labs raised $75 million in Series B funding from Patrick Soon-Shiong, AstraZeneca, and Teradyne to expand its AI-driven robotic clusters, which automate cell and gene therapy manufacturing to cut costs and increase throughput.
FireBrief
FireBrief